BioCentury | Dec 3, 2012
Regulation

A tale of two adjuvants

...III study of the vaccine in 516 patients with chronic kidney disease (CKD). According to clintrials.gov...
BioCentury | Apr 16, 2007
Company News

Phase Forward, Quintiles Transnational Corp. deal

Phase Forward Inc. (PFWD), Waltham, Mass. Quintiles Transnational Corp. (QTRN), Research Triangle Park, N.C. Business: Bioinformatics QTRN extended its license to three of PFWD’s software products: InForm electronic data capture software, Clintrial clinical data management...
BioCentury | Sep 22, 2003
Company News

Axonyx management update

...Hired: S. Colin Neill as CFO and treasurer, formerly SVP, CFO, treasurer and secretary of ClinTrials Research Inc. WIR...
BioCentury | Dec 16, 2002
Company News

Phase Forward, Galt Associates Inc. deal

The companies will offer Phase Forward’s InForm and Clintrial solutions on a single platform with Galt’s dsNavigator enterprise coding and dictionary management technology for clinical and safety data management. Phase Forward Inc. , Waltham, Mass. Galt...
BioCentury | Feb 26, 2001
Company News

ClinTrials, Inveresk Research Group Ltd. deal

...CCRO for $6 per share, or $110.4 million based on CCRO's 18.4 million shares outstanding. ClinTrials Research Inc....
BioCentury | Feb 23, 2001
Company News

Indigo to acquire ClinTrials

Indigo Acquisition, a subsidiary of contract research company Inveresk Research (Edinburgh, U.K.), will acquire the clinical research organization CCRO for $6 per share, or $110.4 million based on CCRO's 18.4 million shares outstanding. BC Staff...
BioCentury | Aug 21, 2000
Company News

ClinTrials management update

ClinTrials Research Inc. (CCRO), Research Triangle Park, N.C. Resigned: Jerry Mitchell as chairman, president and CEO Promoted: Paul Ottaviano to president and CEO from COO WIR Staff...
BioCentury | Aug 21, 2000
Company News

ClinTrials board of directors update

ClinTrials Research Inc. (CCRO), Research Triangle Park, N.C. Transition: Edward Nelson becomes non-executive chairman while remaining a director WIR Staff...
BioCentury | Aug 16, 2000
Company News

ClinTrials Research CEO to resign

Clinical research organization CCRO said its Chairman, President and CEO Jerry Mitchell will resign. CCRO will promote director Edward Nelson to chairman and Paul Ottaviano to president and CEO from COO. Also, CCRO retained ING...
BioCentury | May 30, 2000
Company News

ClinTrials management update

ClinTrials Research Inc. (CCRO), Research Triangle Park, N.C. Business: Supply/Service Hired: Graham May as president for North America, formerly VP of medical affairs and business development at Cytogen Corp. WIR Staff...
Items per page:
1 - 10 of 27
BioCentury | Dec 3, 2012
Regulation

A tale of two adjuvants

...III study of the vaccine in 516 patients with chronic kidney disease (CKD). According to clintrials.gov...
BioCentury | Apr 16, 2007
Company News

Phase Forward, Quintiles Transnational Corp. deal

Phase Forward Inc. (PFWD), Waltham, Mass. Quintiles Transnational Corp. (QTRN), Research Triangle Park, N.C. Business: Bioinformatics QTRN extended its license to three of PFWD’s software products: InForm electronic data capture software, Clintrial clinical data management...
BioCentury | Sep 22, 2003
Company News

Axonyx management update

...Hired: S. Colin Neill as CFO and treasurer, formerly SVP, CFO, treasurer and secretary of ClinTrials Research Inc. WIR...
BioCentury | Dec 16, 2002
Company News

Phase Forward, Galt Associates Inc. deal

The companies will offer Phase Forward’s InForm and Clintrial solutions on a single platform with Galt’s dsNavigator enterprise coding and dictionary management technology for clinical and safety data management. Phase Forward Inc. , Waltham, Mass. Galt...
BioCentury | Feb 26, 2001
Company News

ClinTrials, Inveresk Research Group Ltd. deal

...CCRO for $6 per share, or $110.4 million based on CCRO's 18.4 million shares outstanding. ClinTrials Research Inc....
BioCentury | Feb 23, 2001
Company News

Indigo to acquire ClinTrials

Indigo Acquisition, a subsidiary of contract research company Inveresk Research (Edinburgh, U.K.), will acquire the clinical research organization CCRO for $6 per share, or $110.4 million based on CCRO's 18.4 million shares outstanding. BC Staff...
BioCentury | Aug 21, 2000
Company News

ClinTrials management update

ClinTrials Research Inc. (CCRO), Research Triangle Park, N.C. Resigned: Jerry Mitchell as chairman, president and CEO Promoted: Paul Ottaviano to president and CEO from COO WIR Staff...
BioCentury | Aug 21, 2000
Company News

ClinTrials board of directors update

ClinTrials Research Inc. (CCRO), Research Triangle Park, N.C. Transition: Edward Nelson becomes non-executive chairman while remaining a director WIR Staff...
BioCentury | Aug 16, 2000
Company News

ClinTrials Research CEO to resign

Clinical research organization CCRO said its Chairman, President and CEO Jerry Mitchell will resign. CCRO will promote director Edward Nelson to chairman and Paul Ottaviano to president and CEO from COO. Also, CCRO retained ING...
BioCentury | May 30, 2000
Company News

ClinTrials management update

ClinTrials Research Inc. (CCRO), Research Triangle Park, N.C. Business: Supply/Service Hired: Graham May as president for North America, formerly VP of medical affairs and business development at Cytogen Corp. WIR Staff...
Items per page:
1 - 10 of 27